FAQ

TFE3/PRCC FUSION GENE

Known as: PRCC-TFE3 Fusion Gene, PRCC/TFE3 FUSION GENE, TFE3-PRCC Fusion Gene 
A fusion gene that results from a chromosomal translocation t(X;1)(p11.2;q21.2) which fuses the 5' end of the TFE3 gene to the 3' half of the PRCC… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
0120062018

Related topics

Related topics

1 relation
PRCC/TFE3 Fusion Protein

Related mentions per year

Related mentions per year

1984-2018
19801990200020102020
TFE3/PRCC FUSION GENE
PRCC/TFE3 Fusion Protein

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
Papillary renal cell carcinomas (PRCC) are a histologically and genetically heterogeneous group of tumors that represent 15-20… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Asparagus racemosus leaf extract inhibits growth of UOK 146 renal cell carcinoma cell line: simultaneous oncogenic PRCCTFE3 fusion transcript inhibition and apoptosis independent cell death.
AIMS To evaluate anti-cancer activity of Asparagus racemosus (AR) leaf extract on UOK146, a renal cell carcinoma cell line, and… (More)
  • figure 1
  • table 1
  • figure 5
Is this relevant?
2013
2013
MicroRNA profiles classify papillary renal cell carcinoma subtypes
Background:Besides the conventional clear-cell renal cell carcinoma (ccRCC), papillary RCC (pRCC) is the second most common renal… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2010
2010
Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis
Types 1 and 2 by Delahunt of papillary renal cell carcinoma (PRCC) are traditionally differentiated. An oncocytic variant of PRCC… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Translocation carcinomas of the kidney after chemotherapy in childhood.
PURPOSE Children who survive cancer are at more than 19-fold increased risk of developing another malignancy. Renal cell… (More)
Is this relevant?